205 Results for "

MMP2

" in MedChemExpress (MCE) Product Catalog:
Products (205)

205 Results for "MMP2" in MCE Product Catalog:

  • Isoforms Recommended:
  • Targets Recommended:
  • Recombinant Proteins Recommended:
66
66 Publications Verification
Referencia número: HY-15768
No. CAS: 142880-36-2
Pureza:  98.39%
Synonyms: GM6001; Galardin
Target:  

MMP

Áreas de investigación:  

Cancer

Ilomastat (GM6001) is a potent and broad spectrum matrix metalloprotease (MMP) inhibitor, inhibits MMPs (IC50s, 1.5 nM for MMP-1; 1.1 nM for MMP-2; 1.9 nM for MMP-3; 0.5 nM for MMP-9), with a Ki of 0.4 nM for human skin fibroblast collagenase (MMP-1).
loading...
    loading...
42
42 Cited Publications
Referencia número: HY-N0431
No. CAS: 84687-43-4
Astragaloside IV, an active component isolated from Astragalus membranaceus, suppresses the activation of ERK1/2 and JNK, and downregulates matrix metalloproteases (MMP)-2, (MMP)-9 in MDA-MB-231 breast cancer cells.
loading...
    loading...
29
29 Cited Publications
Referencia número: HY-12354
No. CAS: 292605-14-2
Pureza:  99.67%
Target:  

MMP

Áreas de investigación:  

Cancer

SB-3CT is a potent and competitive matrix metalloproteinase MMP-2 and MMP-9 inhibitor with Ki values of 13.9 and 600 nM, respectively. SB-3CT has high selectivity for gelatinases. SB-3CT shows blood-brain barrier permeability and has neuroprotective effects and anticancer activity [2] .
loading...
    loading...
21
21 Cited Publications
Referencia número: HY-12169
No. CAS: 154039-60-8
Pureza:  99.81%
Synonyms: BB2516; TA2516
Target:  

MMP

Áreas de investigación:  

Cancer

Marimastat (BB2516) is a broad spectrum and orally bioavailable inhibitor of MMPs, with potent activity against MMP-9 (IC50=3 nM), MMP-1 (IC50=5 nM), MMP-2 (IC50=6 nM), MMP-14 (IC50=9 nM) and MMP-7 (IC50=13 nM), used in the treatment of cancer. Marimastat (BB2516) is an angiogenesis and metastasis inhibitor, which limits the growth and production of blood vessels. As an antimetatstatic agent it prevents malignant cells from breaching the basement membranes [2].
loading...
    loading...
20
20 Cited Publications
Referencia número: HY-122022
No. CAS: 2411853-34-2
Pureza:  98.15%
Target:  

mTOR

Áreas de investigación:  

Cancer

JR-AB2-011 is a selective mTORC2 inhibitor with an IC50 value of 0.36 μM. JR-AB2-011 inhibits mTORC2 activity by blocking Rictor-mTOR association (Ki: 0.19 μM) [1].JR-AB2-011 decreases the phosphorylation level of Akt, decreases MMP2 activity, thereby reducing the ability of tumor cells to migrate and invade. JR-AB2-011 also induces non-apoptotic cell death [2].
loading...
    loading...
17
17 Cited Publications
Referencia número: HY-13564
No. CAS: 130370-60-4
Pureza:  98.92%
Synonyms: BB94
Target:  

MMP

Áreas de investigación:  

Cancer

Batimastat is a potent broad spectrum MMP inhibitor with IC50 of 3, 4, 4, 6, and 20 nM for MMP-1, MMP-2, MMP-9, MMP-7 and MMP-3, respectively.
loading...
    loading...
17
17 Cited Publications
Referencia número: HY-13564A
No. CAS: 130464-84-5
Pureza:  99.04%
Synonyms: BB-94 sodium salt
Target:  

MMP

Áreas de investigación:  

Cancer

Batimastat sodium salt is a potent broad spectrum MMP inhibitor with IC50 of 3, 4, 4, 6, and 20 nM for MMP-1, MMP-2, MMP-9, MMP-7 and MMP-3, respectively.
loading...
    loading...
10
10 Cited Publications
Referencia número: HY-N0069
No. CAS: 20311-51-7
Synonyms: Solamargin; δ-Solanigrine
Solamargine, a derivative from the steroidal solasodine in Solanum species, exhibits anticancer activities in numerous types of cancer. Solamargine induces non-selective cytotoxicity and P-glycoprotein inhibition. Solamargine significantly inhibits migration and invasion of HepG2 cells by down-regulating MMP-2 and MMP-9 expression and activity [2].
loading...
    loading...
9
9 Cited Publications
Referencia número: HY-P73296
Pureza:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: 72 kDa Type IV Collagenase; Gelatinase A; MMP-2; TBE-1; CLG4A
Species:  
Source:  
loading...
    loading...
8
8 Cited Publications
Referencia número: HY-B0689
No. CAS: 150378-17-9
Synonyms: MK-639 free base; L-735524 free base
Áreas de investigación:  

Inflammation/Immunology Cancer

Indinavir (MK-639 free base) is an orally active and selective HIV-1 protease inhibitor with a Ki of 0.54 nM for PR. Indinavir exhibits anticancer activity by inhibiting the activation of MMPs-2 hydrolysis, anti-angiogenesis and inducing apoptosis. Indinavir is also a SARS-CoV 3CL pro inhibitor [2] .
loading...
    loading...
8
8 Cited Publications
Referencia número: HY-B0689A
No. CAS: 157810-81-6
Synonyms: MK-639; L735524
Áreas de investigación:  

Infection Cancer

Indinavir sulfate (MK-639) is an orally active and selective HIV-1 protease inhibitor with a Ki of 0.54 nM for PR. Indinavir sulfate exhibits anticancer activity by inhibiting the activation of MMPs-2 hydrolysis, anti-angiogenesis and inducing apoptosis. Indinavir sulfate is also a SARS-CoV 3CL pro inhibitor [2] .
loading...
    loading...
7
7 Cited Publications
Referencia número: HY-107394
No. CAS: 230961-08-7
Pureza:  98.51%
Target:  

MMP

Áreas de investigación:  

Inflammation/Immunology Cancer

UK 356618 (Compound 4j) is a potent and selective inhibitor of matrix metalloprotease-3 (MMP-3) with an IC50 of 5.9 nM. UK 356618 is less potent against MMP-1, MMP-2, MMP-9, MMP-13 and MMP-14 compared with MMP-3 .
loading...
    loading...
6
6 Cited Publications
Referencia número: HY-B0493
No. CAS: 4394-00-7
Target:  

Chloride Channel COX

Áreas de investigación:  

Inflammation/Immunology Cancer

Niflumic acid is a calcium-activated chloride channel blocker and COX-2 inhibitor with the IC50 value of 100 nM. Niflumic acid induces apoptosis through caspase-8/Bid/Bax pathway in lung cancer cells. Niflumic acide exhibits anti-tumor activity by affecting the expression of ERK1/2 and the activity of MMP2 and MMP9. Niflumic acid has orally bioactivity. Niflumic acid acts on rheumatoid arthritis [2] .
loading...
    loading...
6
6 Cited Publications
Referencia número: HY-122214
No. CAS: 775294-71-8
Pureza:  99.84%
Target:  

Autophagy

Áreas de investigación:  

Cancer

AC-73 is a first specific, orally active inhibitor of cluster of differentiation 147 (CD147), which specifically disrupts CD147 dimerization, thereby mainly suppressing the CD147/ERK1/2/STAT3/MMP-2 pathways. AC-73 inhibits the motility and invasion of hepatocellular carcinoma cells . AC-73 is also an anti-proliferative agent and an inducer of autophagy in leukemic cells [2].
loading...
    loading...
5
5 Cited Publications
Referencia número: HY-110397
No. CAS: 1365803-52-6
Pureza:  99.18%
Target:  

MMP

Áreas de investigación:  

Cardiovascular Disease

KP-457 is a selective a disintegrin and metalloproteinase 17 (ADAM17) inhibitor, with higher selectivity for ADAM17 than for other MMPs and ADAM10, and IC50s are 11.1 nM (ADAM17), 748 nM (ADAM10), 717 nM (MMP2), 9760 nM (MMP3), 2200 nM (MMP8), 5410 nM (MMP9), 930 nM (MMP13), 2140 nM (MMP14), and 7100 nM (MMP17), respectively.
loading...
    loading...
5
5 Cited Publications
Referencia número: HY-N0084
No. CAS: 13159-28-9
Synonyms: Betulinic aldehyde; Betunal
Betulinaldehyde (Betunal) Has anti-cancer and anti-staphylococcus aureus activity. Betulinaldehyde Suppressible Akt, MAPK sum STAT3 Signal path, increase self-transfer, Suppression A549 Cellular vitality, increase and transfer. Betulinaldehyde suppresses PLCγ1/Ca 2+/MMP9 signal pathway, has a key effect on vascular plasticity, and is available for cardiovascular disease (CVD) research.
loading...
    loading...
5
5 Cited Publications
Referencia número: HY-N0853
No. CAS: 19885-10-0
Alisol A is an orally active tetracyclic triterpenoid compound of the prototerpane type. Alisol A can be extracted from the rhizome of Alisma orientale. Alisol A activates AMPK/ACC/SREBP-1c, SIRT1, PPARα, inhibits MMP-2/-9, decreases inflammatory cytokine expression (IL-1β, IL-6, IL-8). Alisol A has anti-tumor activity against breast cancer and colorectal cancer. Alisol A has anti-obesity and anti-atherosclerotic activities. Alisol A can be used in the research of hepatitis B, breast cancer, colorectal cancer, atherosclerosis, and obesity [2] .
loading...
    loading...
4
4 Cited Publications
Referencia número: HY-10398
No. CAS: 193022-04-7
Pureza:  99.24%
Synonyms: Ro 1130830; RS 130830
Target:  

MMP

Áreas de investigación:  

Cancer

CTS-1027 is a potent small molecule inhibitor of MMPs, with IC50s of 0.3 nM, 0.5 nM for MMP2, MMP13, respectively, and has > 1,000 fold selectivity over MMP1.
loading...
    loading...
4
4 Cited Publications
Referencia número: HY-12170
No. CAS: 192329-42-3
Pureza:  99.27%
Synonyms: AG3340; KB-R9896
Target:  

MMP Apoptosis

Áreas de investigación:  

Cancer

Prinomastat (AG3340) is a broad spectrum, potent, orally active metalloproteinase (MMP) inhibitor with IC50s of 79, 6.3 and 5.0 nM for MMP-1, MMP-3 and MMP-9, respectively. Prinomastat inhibits MMP-2, MMP-3, MMP-13 and MMP-9 with Kis of 0.05 nM, 0.3 nM, 0.03 nM and 0.26 nM, respectively. Prinomastat crosses blood-brain barrier. Antitumor avtivity [2] .
loading...
    loading...
4
4 Cited Publications
Referencia número: HY-12170A
No. CAS: 1435779-45-5
Pureza:  98.18%
Synonyms: AG3340 hydrochloride; KB-R9896 hydrochloride
Target:  

MMP Apoptosis

Áreas de investigación:  

Cancer

Prinomastat hydrochloride (AG3340 hydrochloride) is a broad spectrum, potent, orally active metalloproteinase (MMP) inhibitor with IC50s of 79, 6.3 and 5.0 nM for MMP-1, MMP-3 and MMP-9, respectively. Prinomastat hydrochloride inhibits MMP-2, MMP-3, MMP-13 and MMP-9 with Kis of 0.05 nM, 0.3 nM, 0.03 nM and 0.26 nM, respectively. Prinomastat hydrochloride can cross blood-brain barrier. Antitumor avtivity [2] .
loading...
    loading...